Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA-splicing endonuclease subunit Sen15 (TSEN15) is a non-catalytic component of the human tRNA splicing endonuclease complex, which is responsible for the precise identification and cleavage of splice sites within intron-containing pre-tRNAs during tRNA maturation. While essential for RNA processing and normal neurodevelopment, TSEN15 itself does not possess enzymatic activity but is required for the structural integrity and function of the enzyme complex. Recessive mutations in the TSEN15 gene can cause pontocerebellar hypoplasia and progressive microcephaly, resulting in developmental delays, intellectual disability, and, less frequently, epilepsy. TSEN15 is not considered a receptor or a common therapeutic target, and no drugs are known to interact directly with this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA-splicing endonuclease subunit Sen15 (TSEN15).